🇬🇧·Jan 13Research
CSCI's Teichmann Lab and GSK announce new partnership to advance our understanding of the role of cells and tissues in disease, paving the way for new medical breakthroughs
Publisher
C
Cambridge Stem Cell Institute
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Cambridge Stem Cell Institute
- Region
- UK
- Scope
- Research
- Published
- January 13, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on stemcells.cam.ac.uk
Leave the platform to read the original full article on the publisher site.
Source: Cambridge Stem Cell Institute
Scope: Research
Related coverage
More related coverage
PubMed — Nephrology & renal therapeutics/5h ago
From mechanism to therapeutics: targeting the mitogen-activated protein kinase 1 (MAPK1)/extracellular signal-regulated kinase 2 (ERK2) pathway in renal fibrosis.
PubMed — Nephrology & renal therapeutics/5h ago
Comparing the outcomes of non-papillary versus papillary mini-percutaneous nephrolithotomy for treatment of multiple renal stones: a prospective randomized study.
PubMed — Nephrology & renal therapeutics/5h ago
Two versus four weeks ureteral stenting prior to flexible ureteroscopy after failed primary ureteral access sheath insertion: a randomized trial.
PubMed — Nephrology & renal therapeutics/5h ago